- Home
- ACNT vs BDTX Comparison
ACNT vs BDTX Comparison
Compare ACNT & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ACNT | BDTX |
|---|---|---|
| Founded | 1945 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Steel/Iron Ore | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 161.0M | 116.8M |
| IPO Year | 1995 | 2020 |
Fundamental Metrics
Financial Performance| Metric | ACNT | BDTX |
|---|---|---|
| Price | $12.79 | $2.12 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $10.40 |
| AVG Volume (30 Days) | 125.5K | ★ 564.6K |
| Earning Date | 06-15-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 106.72 | 32.45 |
| EPS | 0.09 | ★ 0.65 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $143.44 | ★ $3.28 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $11.62 | $1.20 |
| 52 Week High | $17.92 | $4.94 |
Technical Indicators
Market Signals| Indicator | ACNT | BDTX |
|---|---|---|
| Relative Strength Index (RSI) | 20.15 | 40.78 |
| Support Level | $12.08 | $1.93 |
| Resistance Level | $13.06 | $2.67 |
| Average True Range (ATR) | 0.60 | 0.14 |
| MACD | -0.44 | -0.01 |
| Stochastic Oscillator | 5.81 | 26.76 |
Price Performance
Historical ComparisonAbout ACNT Ascent Industries Co.
Ascent Industries Co specializes in development, production, and distribution of specialty chemicals. The company produces specialty ingredients and products for the oil and gas, household, industrial and institutional, personal care, coatings, adhesive, sealants, elastomers, pulp and paper, textile, automotive, agricultural, water, treatment, and construction industries. The products of the company include: Surfactants, Defoamers, Flame Retardants, Emulsifiers, Lubricants, Plasticizers, Straight Esters and Others.
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.